Comparison Between Adalimumab and Infliximab in Perianal Crohn’s Disease: A Systematic Review and Meta-Analysis
Background and Aims: Anti–tumor necrosis factor therapy has been a mainstay of medical management of perianal Crohn’s disease (CD). This systematic review and meta-analysis aimed to compare the efficacy of adalimumab (ADA) and infliximab (IFX) for the treatment of perianal fistulizing CD. Methods: W...
| 出版年: | Gastro Hep Advances |
|---|---|
| 主要な著者: | Tarek Aboursheid, Azizullah Beran, Mohamad Hijazi, Mhd Kutaiba Albuni, Bisher Sawaf, John J. Guardiola, Khaled Abdeljawad, Benjamin D. McDonald, David T. Rubin |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Elsevier
2025-01-01
|
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2772572325000846 |
類似資料
Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
著者:: Yoon Suk Jung, 等
出版事項: (2021-01-01)
著者:: Yoon Suk Jung, 等
出版事項: (2021-01-01)
Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn’s disease: a retrospective cohort study
著者:: Ping Zhu, 等
出版事項: (2022-01-01)
著者:: Ping Zhu, 等
出版事項: (2022-01-01)
Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn’s Disease
著者:: Deng F, 等
出版事項: (2021-07-01)
著者:: Deng F, 等
出版事項: (2021-07-01)
Higher induction and maintenance infliximab trough levels are associated with radiological perianal fistula healing in pediatric patients with Crohn's disease
著者:: Joonhyuk Son, 等
出版事項: (2025-05-01)
著者:: Joonhyuk Son, 等
出版事項: (2025-05-01)
Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
著者:: Tatyana Valentinovna Mezenova, 等
出版事項: (2012-04-01)
著者:: Tatyana Valentinovna Mezenova, 等
出版事項: (2012-04-01)
Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)
出版事項: (2016-05-01)
出版事項: (2016-05-01)
Comparison of long-term outcomes of infliximab and adalimumab therapy in biologic-naive patients with ulcerative colitis
著者:: Muhammed B. Durak, 等
出版事項: (2025-01-01)
著者:: Muhammed B. Durak, 等
出版事項: (2025-01-01)
A patient had Crohn's disease with perianal abscess
著者:: Tao Li, 等
出版事項: (2023-08-01)
著者:: Tao Li, 等
出版事項: (2023-08-01)
SAFETY PROFILE OF ANTI-TNF THERAPY IN CROHN’S DISEASE MANAGEMENT: A BRAZILIAN SINGLE-CENTER DIRECT RETROSPECTIVE COMPARISON BETWEEN INFLIXIMAB AND ADALIMUMAB
著者:: Mariella BAU, 等
出版事項: (2017-09-01)
著者:: Mariella BAU, 等
出版事項: (2017-09-01)
Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis
著者:: Fares Ayoub, 等
出版事項: (2022-04-01)
著者:: Fares Ayoub, 等
出版事項: (2022-04-01)
Self-screening questionnaire for perianal fistulizing disease in patients with Crohn’s disease
著者:: O Seong Kweon, 等
出版事項: (2024-05-01)
著者:: O Seong Kweon, 等
出版事項: (2024-05-01)
Effect of Infliximab and Adalimumab on Experimental Colitis Following Orally Supplemented Iron
著者:: John Triantafillidis, 等
出版事項: (2017-01-01)
著者:: John Triantafillidis, 等
出版事項: (2017-01-01)
Current Overview on the Use of Mesenchymal Stem Cells for Perianal Fistula Treatment in Patients with Crohn’s Disease
著者:: Marcin Włodarczyk, 等
出版事項: (2021-10-01)
著者:: Marcin Włodarczyk, 等
出版事項: (2021-10-01)
Association between Fecal Calprotectin and Mucosal Healing in Pediatric Patients with Crohn’s Disease Who Have Achieved Sustained Clinical Remission with Anti-Tumor Necrosis Factor Agents
著者:: Yoo Min Lee, 等
出版事項: (2022-01-01)
著者:: Yoo Min Lee, 等
出版事項: (2022-01-01)
Safety profile and side effects of infliximab and adalimumab in inflammatory bowel disease at a referral center in northeastern Brazil
著者:: Joelma Aurélio de Sousa Santos, 等
出版事項: (2024-02-01)
著者:: Joelma Aurélio de Sousa Santos, 等
出版事項: (2024-02-01)
Efficacy of ileostomy in Crohn's disease of the large intestine with perianal involvement
著者:: Yu. A. Shelygin, 等
出版事項: (2011-12-01)
著者:: Yu. A. Shelygin, 等
出版事項: (2011-12-01)
Mesenchymal Stem Cells for Perianal Crohn’s Disease
著者:: Michele Carvello, 等
出版事項: (2019-07-01)
著者:: Michele Carvello, 等
出版事項: (2019-07-01)
Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis
著者:: Weishai Liu, 等
出版事項: (2023-05-01)
著者:: Weishai Liu, 等
出版事項: (2023-05-01)
Long-Term Outcome of Surgery for Perianal Crohn’s Fistula
著者:: Marie Schaad, 等
出版事項: (2024-06-01)
著者:: Marie Schaad, 等
出版事項: (2024-06-01)
Certolizumab pegol in treatment of Crohn's disease with perianal lesions
著者:: I L Khalif, 等
出版事項: (2018-04-01)
著者:: I L Khalif, 等
出版事項: (2018-04-01)
Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
著者:: Rintaro Moroi, 等
出版事項: (2019-01-01)
著者:: Rintaro Moroi, 等
出版事項: (2019-01-01)
Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients
著者:: Raquel Campanilho-Marques, 等
出版事項: (2020-04-01)
著者:: Raquel Campanilho-Marques, 等
出版事項: (2020-04-01)
Effects of Perianal Involvement on Clinical Outcomes in Crohn’s Disease over 10 Years
著者:: Jin Young Yoon, 等
出版事項: (2018-05-01)
著者:: Jin Young Yoon, 等
出版事項: (2018-05-01)
Research advances in diagnosis and treatment of Crohn’s disease presenting with perianal fistula as the initial symptom
著者:: Fan Lingyan, 等
出版事項: (2025-04-01)
著者:: Fan Lingyan, 等
出版事項: (2025-04-01)
Validation of the i-Tracker Drug and Total Anti-Drug Antibody CLIA Assays on IDS-iSYS for Therapeutic Drug Monitoring in Adalimumab- and Infliximab-Treated Patients
著者:: Akpedje Serena Dossou, 等
出版事項: (2025-09-01)
著者:: Akpedje Serena Dossou, 等
出版事項: (2025-09-01)
Successful Treatment of Postoperative Fistula with Infliximab in a Patient with Crohn's Disease
著者:: Seong Yeon Jeong, 等
出版事項: (2014-01-01)
著者:: Seong Yeon Jeong, 等
出版事項: (2014-01-01)
Treatment of perianal fistulas in Crohn’s disease - review of literature and current recommendations
著者:: Dominik Szawica, 等
出版事項: (2023-04-01)
著者:: Dominik Szawica, 等
出版事項: (2023-04-01)
Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease
著者:: Luis Eduardo Miani Gomes, 等
出版事項: (2019-04-01)
著者:: Luis Eduardo Miani Gomes, 等
出版事項: (2019-04-01)
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
著者:: M Rodgers, 等
出版事項: (2011-02-01)
著者:: M Rodgers, 等
出版事項: (2011-02-01)
Is Routine Pathological Analysis of Perianal Fistula Specimen Necessary in Diagnosis of Crohn's Disease?
著者:: Steve Y. C. Lau, 等
出版事項: (2020-03-01)
著者:: Steve Y. C. Lau, 等
出版事項: (2020-03-01)
Impact of Biologic Treatment of Crohn’s Disease on the Rate of Surgeries and Other Healthcare Resources: An Analysis of a Nationwide Database From Poland
著者:: Przemysław Holko, 等
出版事項: (2018-06-01)
著者:: Przemysław Holko, 等
出版事項: (2018-06-01)
Advances in surgical diagnosis and treatment of perianal fistulizing Crohn’s disease
著者:: Liu Zhiwei, 等
出版事項: (2025-02-01)
著者:: Liu Zhiwei, 等
出版事項: (2025-02-01)
Adalimumab and azathioprine in the prevention of postoperative crohn’s disease recurrence
著者:: A. V. Poletova, 等
出版事項: (2020-10-01)
著者:: A. V. Poletova, 等
出版事項: (2020-10-01)
Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis
著者:: Han Wang, 等
出版事項: (2022-11-01)
著者:: Han Wang, 等
出版事項: (2022-11-01)
Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia
著者:: Choon Jin Ooi, 等
出版事項: (2019-07-01)
著者:: Choon Jin Ooi, 等
出版事項: (2019-07-01)
Early diagnosis and treatment of perianal Crohn's disease in a 1‐year‐old infant: Case report and review of literature
著者:: Marah Mansour, 等
出版事項: (2024-06-01)
著者:: Marah Mansour, 等
出版事項: (2024-06-01)
Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a disproportionality analysis from the FAERS database
著者:: Yanhong Deng, 等
出版事項: (2025-08-01)
著者:: Yanhong Deng, 等
出版事項: (2025-08-01)
Efficacy of Adalimumab in Korean Patients with Crohn’s Disease
出版事項: (2016-03-01)
出版事項: (2016-03-01)
Vaginal delivery in women with perianal Crohn's disease: why not?AJOG Global Reports at a Glance
著者:: Irene J. Schaafsma, MSc, 等
出版事項: (2024-05-01)
著者:: Irene J. Schaafsma, MSc, 等
出版事項: (2024-05-01)
Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn’s Disease
著者:: Maja Hanić, 等
出版事項: (2023-06-01)
著者:: Maja Hanić, 等
出版事項: (2023-06-01)
類似資料
-
Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
著者:: Yoon Suk Jung, 等
出版事項: (2021-01-01) -
Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn’s disease: a retrospective cohort study
著者:: Ping Zhu, 等
出版事項: (2022-01-01) -
Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn’s Disease
著者:: Deng F, 等
出版事項: (2021-07-01) -
Higher induction and maintenance infliximab trough levels are associated with radiological perianal fistula healing in pediatric patients with Crohn's disease
著者:: Joonhyuk Son, 等
出版事項: (2025-05-01) -
Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
著者:: Tatyana Valentinovna Mezenova, 等
出版事項: (2012-04-01)
